5 December 2007
Microgen plc (the "Company")
Notification of Interests of Directors and Connected Persons
In accordance with DR 3.1.4R (1) (a) and (b) the Company announces that on 4
December 2007 its Chairman, Martyn Ratcliffe, acquired 210,000 Ordinary Shares
in the Company representing 0.20% of the issued class, at the following price:
100,000 at 40 pence
85,000 at 40.75 pence
25,000 at 42 pence
Following this transaction, Mr Ratcliffe's total beneficial shareholding is
5,019,524 shares, representing 4.88% of the issued class.
If you require further information please contact:
G.E. Liddle, Company Secretary
Tel: 01252 772 313
www.microgen.co.uk
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.